1. Home
  2. BAFN vs VNRX Comparison

BAFN vs VNRX Comparison

Compare BAFN & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

HOLD

Current Price

$7.80

Market Cap

40.6M

Sector

Finance

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.25

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAFN
VNRX
Founded
1999
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
38.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BAFN
VNRX
Price
$7.80
$0.25
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.50
AVG Volume (30 Days)
5.9K
2.0M
Earning Date
01-29-2026
11-13-2025
Dividend Yield
2.05%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,931,000.00
$1,472,007.00
Revenue This Year
N/A
$55.98
Revenue Next Year
N/A
$420.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.48
52 Week Low
$6.40
$0.23
52 Week High
$19.75
$0.94

Technical Indicators

Market Signals
Indicator
BAFN
VNRX
Relative Strength Index (RSI) 39.35 33.85
Support Level $7.80 $0.25
Resistance Level $8.49 $0.27
Average True Range (ATR) 0.15 0.02
MACD 0.02 0.00
Stochastic Oscillator 10.14 19.87

Price Performance

Historical Comparison
BAFN
VNRX

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: